Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2CNS 1

Conditions

Polycystic Ovary Syndrome 8Neoplasm Metastasis 5Breast Neoplasms 5Neoplasms 3Recurrence 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Obesity 2Multiple Myeloma 2Metabolic Diseases 2Leukemia, Lymphocytic, Chronic, B-Cell 2Insulin Resistance 2Infertility 2Glioblastoma 2Carcinoma, Ovarian Epithelial 2Brain Neoplasms 2Weight Loss 1Waldenstrom Macroglobulinemia 1Thrombocytopenia 1TP53 Y220C Mutation 1Splenomegaly 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Mycosis Fungoides 1Mouth Neoplasms 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Metformin × Clear all
NCT03017833 2023-10-04

Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers

M.D. Anderson Cancer Center

Phase 1 Completed
31 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT01528046 2023-01-13

Metformin in Children With Relapsed or Refractory Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
26 enrolled
CNS

Brain Neoplasms, Neoplasms, Recurrence

NCT01442870 2017-05-09

Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy

Tufts Medical Center

Phase 1 Completed
105 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡